FI981624A0 - Compositions and methods for administration of Borrelia burgdorferi antigens - Google Patents

Compositions and methods for administration of Borrelia burgdorferi antigens

Info

Publication number
FI981624A0
FI981624A0 FI981624A FI981624A FI981624A0 FI 981624 A0 FI981624 A0 FI 981624A0 FI 981624 A FI981624 A FI 981624A FI 981624 A FI981624 A FI 981624A FI 981624 A0 FI981624 A0 FI 981624A0
Authority
FI
Finland
Prior art keywords
administration
compositions
methods
borrelia burgdorferi
burgdorferi antigens
Prior art date
Application number
FI981624A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI981624A (en
Inventor
Alan G Garbour
Catherine J Luke
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK590288A external-priority patent/DK590288D0/en
Application filed by Univ Texas filed Critical Univ Texas
Publication of FI981624A0 publication Critical patent/FI981624A0/en
Publication of FI981624A publication Critical patent/FI981624A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
FI981624A 1988-10-24 1998-07-16 Compositions and Methods for Administering Borrelia burgdorferi Antigens FI981624A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK590288A DK590288D0 (en) 1988-10-24 1988-10-24 CHEMICAL COMPOUNDS
US42288189A 1989-10-18 1989-10-18
US92479892A 1992-08-06 1992-08-06
US08/079,601 US5523089A (en) 1988-10-24 1993-06-22 Borrelia antigen
US08/588,637 US7094391B1 (en) 1988-10-24 1996-01-19 Compositions and methods for administering Borrelia burgdorferi antigens
PCT/US1997/000557 WO1997026006A1 (en) 1988-10-24 1997-01-17 Compositions and methods for administering borrelia burgdorferi antigens

Publications (2)

Publication Number Publication Date
FI981624A0 true FI981624A0 (en) 1998-07-16
FI981624A FI981624A (en) 1998-08-05

Family

ID=36821664

Family Applications (1)

Application Number Title Priority Date Filing Date
FI981624A FI981624A (en) 1988-10-24 1998-07-16 Compositions and Methods for Administering Borrelia burgdorferi Antigens

Country Status (8)

Country Link
US (1) US7094391B1 (en)
EP (1) EP0876156A4 (en)
JP (1) JP2000507209A (en)
AU (1) AU740048B2 (en)
FI (1) FI981624A (en)
NO (1) NO983220L (en)
WO (1) WO1997026006A1 (en)
ZA (1) ZA97459B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2460538C2 (en) 2006-11-03 2012-09-10 Шеринг-Плоу Лтд. Dog lyme borreliosis vaccine
WO2008101667A1 (en) * 2007-02-22 2008-08-28 Baxter International Inc. Method of purification of hydrophobic proteins
KR102085465B1 (en) 2010-05-14 2020-03-05 박스알타 인코퍼레이티드 Chimeric ospa genes, proteins, and methods of use thereof
US9023367B2 (en) 2012-07-27 2015-05-05 Baxter International Inc. Compositions comprising chimeric OSPA molecules and methods of use thereof
JP7008900B2 (en) * 2015-06-02 2022-02-10 イントラヴァック ビー．ブイ． Surface presentation of antigen in Gram-negative outer membrane vesicles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (en) * 1988-10-24 1988-10-24 Symbicom Ab CHEMICAL COMPOUNDS
GB1596653A (en) * 1977-01-26 1981-08-26 Gist Brocades Nv Vaccine
IT1223777B (en) * 1988-08-18 1990-09-29 Gevipi Ag TWO-OUTLET TAP WITH DEPRESSION INVERTER
DE4015911A1 (en) * 1989-09-19 1991-03-28 Max Planck Gesellschaft VACCINE AGAINST LYME DISEASE
CA2084413A1 (en) * 1990-06-15 1991-12-16 Richard A. Flavell Compositions and methods for the prevention and diagnosis of lyme disease

Also Published As

Publication number Publication date
NO983220L (en) 1998-09-14
ZA97459B (en) 1997-08-04
FI981624A (en) 1998-08-05
US7094391B1 (en) 2006-08-22
WO1997026006A1 (en) 1997-07-24
EP0876156A1 (en) 1998-11-11
AU1747097A (en) 1997-08-11
AU740048B2 (en) 2001-10-25
NO983220D0 (en) 1998-07-13
JP2000507209A (en) 2000-06-13
EP0876156A4 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
FI893520A0 (en) Process for the preparation of an intravenous pharmaceutical composition
FI95246B (en) Process for the preparation of therapeutically useful substituted aminomethylbenzodihydropyrans and aminomethyl (di- and tetra) hydronaphthalenes
FI101453B (en) Method and DNA Sequences for Preparation of Recombinant Coccidio Sis Vaccine
FI973039A (en) New farnecyltransferase inhibitors, their preparation, and these containing pharmaceutical compositions
FI883583A (en) Polymer particles and their preparation
IT1232831B (en) ADSORBATED RESIN, PROCEDURE TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
LV10573A (en) Attenuation for pharmaceutical formulation
FI950420A (en) Crystalline amyphostine compositions and methods of preparation and use thereof
FI885274A (en) Process for the preparation of chewing gum and chewing gum compositions
FI95914C (en) Polypeptide derivatives and process for their preparation
FI981624A0 (en) Compositions and methods for administration of Borrelia burgdorferi antigens
PT87024A (en) PROCESS FOR THE PREPARATION OF PROPIOLOPHENONE DERIVATIVES AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FI942222A (en) Process for the preparation of dry-treated particles, so obtained dry-treated particles and pharmaceutical compositions containing them
FI955123A0 (en) Composition containing cholestyramine and process for preparation thereof
FI88705C (en) Polyarylalkanes oligomer compositions and methods for their preparation
IL80246A0 (en) Phenyl(naphthyl)alkanol derivatives,their preparation and pharmaceutical compositions containing them
DK449188D0 (en) 2'-DEOXY-5-FLUORURIDIN DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
KR900700471A (en) New 2,3-thiomorpholine dione-2-oxime derivatives, pharmaceutical compositions and preparations containing them
IT8421431A1 (en) "NEW PHARMACEUTICAL PREPARATIONS WITH ANTI-TUMOR ACTION"
IL125323A0 (en) Compositions and methods for administering borrelia burgdorferi antigens
SE448090B (en) TIOKARNITINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE
AP8900157A0 (en) Pharmaceutical compositions for regeneration of leukocytes
SE8804317A0 (en) Compositions for reducing phlebectasia and process for their preparation
IT8922446A0 (en) PROCEDURE FOR THE PREPARATION OF WATER-SOLUBLE PRIMICIN AND ITS COMPONENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2554446B1 (en) DIAMIDES DERIVED FROM AZABICYCLOALCANES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
MA Patent expired